Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Fig. 4

Second and later lines of treatment. Patients 61–65 years of age. Percentage of patients given different treatments in the two periods. Period 1 = 01.01.2001–31.06.2005 Period 2 = 01.01.2005–31.12.2009. Sec ASCT = Salvage ASCT, VAD = Vincristin-Adriamycine- dexamethasone, MP = Melphalan- Prednisolone, Cyclo = Cyclophosphamide, Thal = Thalidomide, Pom = Pomalidomide, Benda = Bendamustin

Back to article page